United Arab Emirates vs Zimbabwe: Pneumococcal conjugate second or third-dose vaccines (PCVc)
United Arab Emirates
91.0%
in 2025
Zimbabwe
91.0%
in 2025
United Arab Emirates rank
61st
Zimbabwe rank
61st
Pneumococcal conjugate second or third-dose vaccines (PCVc) over time
- United Arab Emirates
- Zimbabwe
How they compare
United Arab Emirates currently reports 91.0% against 91.0% in Zimbabwe, a difference of 0.0%.
The two have swapped places 4 times across 18 shared years of data; in 2008 it was Zimbabwe ahead.
United Arab Emirates ranks 61st and Zimbabwe ranks 61st of 194 countries.
United Arab Emirates has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | United Arab Emirates | Zimbabwe | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | — |
| 2010s | 97.4% | 65.2% | 32.2% | United Arab Emirates |
| 2020s | 92.2% | 89.3% | 2.8% | United Arab Emirates |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc), United Arab Emirates or Zimbabwe?
- United Arab Emirates, at 91.0% against 91.0% in Zimbabwe as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) between United Arab Emirates and Zimbabwe?
- 0.0%, with United Arab Emirates ahead.
- How many years of comparable data are there for United Arab Emirates and Zimbabwe?
- 18 years are reported by both, from 2008 to 2025.
- How do United Arab Emirates and Zimbabwe rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- United Arab Emirates ranks 61st and Zimbabwe ranks 61st of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.